Neuronetics Announces NeuroStar TMS Therapy Will be Featured On The Dr. Oz Show
Segment to air during March 14th episode
Neuronetics, Inc. is pleased to announce that TMS (transcranial magnetic stimulation) Therapy will be featured on an upcoming episode of The Dr. Oz Show. The episode, which is scheduled to air on Wednesday, March 14th, will feature TMS Therapy® as a depression treatment option for patients who have not benefited from initial antidepressant medication. The segment may also include a demonstration of the NeuroStar TMS Therapy® system as well as an interview with Dr. Tarique Perera, a NeuroStar provider, and one of his TMS treated patients. The Dr. Oz Show, which typically airs in the afternoon, is America’s number one rated talk show with 3.8 million daily viewers. For exact air times, please check your local listings or log on to www.doctoroz.com.
NeuroStar TMS Therapy
Neuronetics’ NeuroStar TMS Therapy system was cleared by the FDA in October 2008 for the treatment of Major Depressive Disorder. NeuroStar TMS Therapy is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. NeuroStar TMS Therapy is a non-systemic (does not circulate in the bloodstream throughout the body) and noninvasive (does not involve surgery) form of neuromodulation. It stimulates nerve cells in an area of the brain that has been linked to depression by delivering highly focused MRIstrength magnetic field pulses. The treatment is typically administered daily for 4-6 weeks. NeuroStar TMS Therapy is available by prescription only. For full safety and prescribing information, visit www.NeuroStar.com.